Superworth

Eli Lilly and forward PE LLY

Share price divided by analysts' consensus earnings for the next twelve months, since 1994.

Today, Oct 23, 2026
33.9×
10-year median
28.3×
Against its 10-year history
63rd
percentile: 0 is its lowest day, 100 its highest
10-year range
15.5× to 82.1×
Peer median
17.5×

Eli Lilly and's forward PE is 33.9× as of Oct 23, 2026.

That is above its ten-year median of 28.3×, close to the middle of its last ten years.

Over that time it ranged from 15.5× in May 2018 to 82.1× in Oct 2023.

The median for 7 large drugmakers of a similar size is 17.5×.

Forward PE over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far33.9×27.5×41.7×
202541.6×24.1×42.9×
202440.0×38.1×76.1×
202365.3×53.2×82.1×
202267.7×29.1×69.3×
202133.1×19.9×33.1×
202020.2×15.6×22.2×
201921.0×17.6×22.8×
201820.7×15.5×21.5×
201719.5×19.1×21.8×
201618.6×17.1×23.2×
201523.7×22.1×29.2×
201425.4×18.6×26.1×
201318.7×14.8×18.7×
201214.0×12.4×15.6×
201114.0×7.7×14.0×
20107.8×7.6×9.0×
20098.9×7.6×10.7×
200810.0×8.0×14.6×
200713.9×13.1×17.8×

Against its peers

Companies in Drug Manufacturers - General nearest Eli Lilly and's size, closest first, today.

CompanyForward PE
LLYEli Lilly and33.9×
JNJJohnson & Johnson23.4×
ABBVAbbVie19.0×
MRKMerck17.5×
AMGNAmgen18.6×
GILDGilead Sciences17.2×
PFEPfizer10.9×
BMYBristol-Myers Squibb10.4×
Peer median17.5×

Where Eli Lilly and ranks

What the forward PE tells you

Price divided by what analysts expect the company to earn over the next twelve months. It answers "what am I paying for next year" instead of last year.

Estimates are opinions. When forward PE is far below trailing PE, analysts expect a big jump in earnings. If that jump slips, the stock was not as cheap as it looked.

More on Eli Lilly and

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.